Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P240042/S003

Tendyne Transcatheter Mitral Valve System

ABBOTT MEDICAL · Decision date Aug 7, 2026

FDA DECISIONP240042/S003

What did the FDA decide?

FDA records P240042/S003 as a supplement to PMA P240042, with the supplement type “30-Day Notice”. The recorded decision is OK30 (30-day notice), dated Aug 7, 2026.

FDA approval order statement

a packaging material change
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Aug 7, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record

Regulatory record facts

Identifier
P240042/S003
Regulatory pathway
PMA supplement
Product code
NPU
Decision code
OK30
Decision date
Aug 7, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Prosthesis, mitral valve, percutaneously delivered.

Product code
NPU
FDA device class
3

Review the original FDA PMA listing for the original approval scope and linked supplements.

FDA decision timeline

  1. P240042/S001 · Related supplement

    Tendyne Transcatheter Mitral Valve

  2. P240042/S002 · Related supplement

    Tendyne Transcatheter Mitral Valve System

  3. P240042/S003 received

    Application receipt date recorded by FDA.

  4. P240042/S003 · FDA decision

    30-Day Notice

  5. P240042/S004 · Related supplement

    Tendyne Transcatheter Mitral Valve System

Timeline entries are records held by MedtechLedger for P240042. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P240042

Product / regulatory recordCompanyPathwayDecision dateSource
ABBOTT MEDICALPMA supplementJul 29, 2025FDA
ABBOTT MEDICALPMA supplementOct 4, 2025FDA
ABBOTT MEDICALPMA supplementAug 31, 2026FDA

Explore the linked device profile

Other records with product code NPU

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Abbott Medical

Headquarters
Not reported
Brand website
abbott.com
FDA applicant address
177 County Rd. B E., St. Paul, MN, 55117

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records